Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.
about
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginaseMutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.Therapeutic l-asparaginase: upstream, downstream and beyond.Design and engineering of deimmunized biotherapeutics.Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivo.
P2860
Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@en
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@nl
type
label
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@en
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@nl
prefLabel
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@en
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@nl
P2093
P2860
P356
P1433
P1476
Mapping of B-cell epitopes in ...... me used in leukemia treatment.
@en
P2093
Anne Werner
Hans-Joachim Müller
Klaus-Heinrich Röhm
P2860
P304
P356
10.1515/BC.2005.063
P577
2005-06-01T00:00:00Z